# Hemolung RAS Registry Program

> **NCT01855815** · — · UNKNOWN · sponsor: **Alung Technologies** · enrollment: 99 (estimated)

## Conditions studied

- Acute Hypercapnic Respiratory Failure

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01855815
- **Lead sponsor:** Alung Technologies
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-04
- **Primary completion:** 2019-12
- **Final completion:** 2019-12
- **Target enrollment:** 99 (ESTIMATED)
- **Last updated:** 2019-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01855815

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01855815, "Hemolung RAS Registry Program". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01855815. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*